Updates: MET Targeted Therapy for EXON 14 Mutations in Lung Cancer
Impact Journals - Blog,
“The future looks bright for patients with MET mutations and NSCLC.” BUFFALO, NY- September 11, 2023 – A new editorial paper…
“The future looks bright for patients with MET mutations and NSCLC.” BUFFALO, NY- September 11, 2023 – A new editorial paper…
PRESS RELEASE: On May 26, 2023, a new editorial was published in Oncotarget, entitled, “Latest updates on MET targeted therapy…